
Company Number
03854291
Next Accounts
Sep 2025
Shareholders
matrix bidco limited
Group Structure
View All
Industry
Activities of head offices
Registered Address
c/o biocomposites limited, keele science park, newcastle, staffs, ST5 5NL
Website
www.biocomposites.comPomanda estimates the enterprise value of BIOCOMPOSITES (UK) LIMITED at £0 based on a Turnover of £0 and 0.47x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of BIOCOMPOSITES (UK) LIMITED at £16.8m based on an EBITDA of £4.6m and a 3.61x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of BIOCOMPOSITES (UK) LIMITED at £14m based on Net Assets of £7m and 1.99x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biocomposites (uk) Limited is a live company located in newcastle, ST5 5NL with a Companies House number of 03854291. It operates in the activities of head offices sector, SIC Code 70100. Founded in October 1999, it's largest shareholder is matrix bidco limited with a 100% stake. Biocomposites (uk) Limited is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Pomanda's financial health check has awarded Biocomposites (Uk) Limited a 0.5 rating. We use a traffic light system to show it exceeds the industry average on 0 measures and has 3 areas for improvement. Company Health Check FAQs
0 Strong
1 Regular
3 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Biocomposites (uk) Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Biocomposites (uk) Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Biocomposites (uk) Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Biocomposites (uk) Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (110)
- Biocomposites (uk) Limited
- - Industry AVG
Pay Structure
on an average salary of £49.9k, the company has an equivalent pay structure (£49.9k)
- Biocomposites (uk) Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Biocomposites (uk) Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Biocomposites (uk) Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Biocomposites (uk) Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Biocomposites (uk) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (15 weeks)
- - Biocomposites (uk) Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 88.1%, this is a higher level of debt than the average (55.7%)
- - Biocomposites (uk) Limited
- - Industry AVG
Biocomposites (Uk) Limited's latest turnover from December 2023 is 0 and the company has net assets of £7 million. According to their latest financial statements, we estimate that Biocomposites (Uk) Limited has 1 employee and maintains cash reserves of £317 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 39,370,000 | 28,110,000 | 20,095,000 | 17,149,000 | 11,596,000 | 8,688,385 | |||||||||
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 1,518,265 | ||||||||||||||
Gross Profit | 7,170,120 | ||||||||||||||
Admin Expenses | 6,516,099 | ||||||||||||||
Operating Profit | 380,000 | 122,000 | 13,105,000 | 7,339,000 | 3,462,000 | 3,277,000 | 1,551,000 | 654,021 | |||||||
Interest Payable | 1,000 | 1,000 | 2,148 | ||||||||||||
Interest Receivable | 3,819,000 | 68,963,000 | 8,000 | 28,000 | 18,000 | 6,000 | 1,000 | 3,946 | |||||||
Pre-Tax Profit | 3,506,000 | 67,265,000 | -12,000 | -1,000 | -52,000 | 2,747,000 | 20,645,000 | 13,113,000 | 7,367,000 | 3,480,000 | 3,282,000 | 1,551,000 | 655,819 | ||
Tax | 51,000 | -85,000 | -2,051,000 | -734,000 | -360,000 | -1,272,000 | -505,000 | -30,022 | |||||||
Profit After Tax | 3,506,000 | 67,265,000 | -12,000 | -1,000 | -52,000 | 2,798,000 | 20,560,000 | 11,062,000 | 6,633,000 | 3,120,000 | 2,010,000 | 1,046,000 | 625,797 | ||
Dividends Paid | 67,500,000 | 23,904,000 | 3,000,000 | ||||||||||||
Retained Profit | 3,506,000 | -235,000 | -12,000 | -1,000 | -52,000 | -21,106,000 | 20,560,000 | 8,062,000 | 6,633,000 | 3,120,000 | 2,010,000 | 1,024,000 | 618,500 | ||
Employee Costs | 9,991,000 | 7,978,000 | 6,501,000 | 5,043,000 | 3,767,000 | 3,160,208 | |||||||||
Number Of Employees | 4 | 4 | 131 | 117 | 102 | 83 | 73 | ||||||||
EBITDA* | 380,000 | 122,000 | 13,332,000 | 7,579,000 | 3,682,000 | 3,470,000 | 1,588,000 | 654,021 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 958,000 | 765,000 | 808,000 | 830,000 | 682,000 | 485,986 | |||||||||
Intangible Assets | |||||||||||||||
Investments & Other | 45,399,000 | 40,312,000 | 651,000 | 651,000 | 651,000 | -2,145,000 | 639,000 | 1,165 | 1,165 | ||||||
Debtors (Due After 1 year) | 16,639,000 | 2,784,000 | 24,347,000 | 1,901,275 | 1,901,275 | ||||||||||
Total Fixed Assets | 45,399,000 | 40,312,000 | 17,290,000 | 651,000 | 651,000 | 639,000 | 24,986,000 | 958,000 | 765,000 | 808,000 | 830,000 | 682,000 | 485,986 | 1,902,440 | 1,902,440 |
Stock & work in progress | 1,091,000 | 1,235,000 | 571,000 | 767,000 | 502,000 | 467,874 | |||||||||
Trade Debtors | 4,991,000 | 3,945,000 | 2,682,000 | 2,101,000 | 1,883,000 | 1,247,811 | |||||||||
Group Debtors | 12,883,000 | 5,675,000 | 13,639,000 | 3,286,000 | |||||||||||
Misc Debtors | 680,000 | 146,000 | 1,878,000 | 1,546,000 | 641,000 | 588,000 | 319,000 | 336,365 | |||||||
Cash | 317,000 | 816,000 | 869,000 | 6,000 | 658,000 | 466,000 | 106,000 | 18,838,000 | 10,550,000 | 6,099,000 | 4,019,000 | 2,035,000 | 1,676,114 | 95 | 95 |
misc current assets | |||||||||||||||
total current assets | 13,880,000 | 6,637,000 | 869,000 | 13,645,000 | 3,944,000 | 3,250,000 | 106,000 | 26,798,000 | 17,276,000 | 9,993,000 | 7,475,000 | 4,739,000 | 3,728,164 | 95 | 95 |
total assets | 59,279,000 | 46,949,000 | 18,159,000 | 14,296,000 | 4,595,000 | 3,889,000 | 25,092,000 | 27,756,000 | 18,041,000 | 10,801,000 | 8,305,000 | 5,421,000 | 4,214,150 | 1,902,535 | 1,902,535 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 1,301,000 | 1,165,000 | 565,000 | 1,068,000 | 431,000 | 361,261 | 3,563 | 3,563 | |||||||
Group/Directors Accounts | 49,735,000 | 43,425,000 | 14,400,000 | 10,525,000 | 823,000 | 38,000 | 1,000 | ||||||||
other short term finances | |||||||||||||||
hp & lease commitments | 14,000 | 6,000 | 6,372 | ||||||||||||
other current liabilities | 2,514,000 | 27,000 | 161,000 | 2,621,000 | 1,847,000 | 1,911,000 | 1,753,000 | 862,000 | 619,982 | ||||||
total current liabilities | 52,249,000 | 43,425,000 | 14,400,000 | 10,525,000 | 823,000 | 65,000 | 162,000 | 3,922,000 | 3,012,000 | 2,476,000 | 2,835,000 | 1,299,000 | 987,615 | 3,563 | 3,563 |
loans | |||||||||||||||
hp & lease commitments | 15,000 | 21,464 | |||||||||||||
Accruals and Deferred Income | 177,000 | 901,000 | 1,077,065 | ||||||||||||
other liabilities | |||||||||||||||
provisions | 283,000 | 210,000 | |||||||||||||
total long term liabilities | 460,000 | 1,126,000 | 1,098,529 | ||||||||||||
total liabilities | 52,249,000 | 43,425,000 | 14,400,000 | 10,525,000 | 823,000 | 65,000 | 162,000 | 3,922,000 | 3,012,000 | 2,476,000 | 3,295,000 | 2,425,000 | 2,086,144 | 3,563 | 3,563 |
net assets | 7,030,000 | 3,524,000 | 3,759,000 | 3,771,000 | 3,772,000 | 3,824,000 | 24,930,000 | 23,834,000 | 15,029,000 | 8,250,000 | 4,935,000 | 2,921,000 | 1,950,664 | 1,898,972 | 1,898,972 |
total shareholders funds | 7,030,000 | 3,524,000 | 3,759,000 | 3,771,000 | 3,772,000 | 3,824,000 | 24,930,000 | 23,834,000 | 15,029,000 | 8,250,000 | 4,935,000 | 2,921,000 | 1,950,664 | 1,898,972 | 1,898,972 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 380,000 | 122,000 | 13,105,000 | 7,339,000 | 3,462,000 | 3,277,000 | 1,551,000 | 654,021 | |||||||
Depreciation | 227,000 | 240,000 | 220,000 | 193,000 | 1,000 | ||||||||||
Amortisation | 36,000 | ||||||||||||||
Tax | 51,000 | -85,000 | -2,051,000 | -734,000 | -360,000 | -1,272,000 | -505,000 | -30,022 | |||||||
Stock | -1,091,000 | -144,000 | 664,000 | -196,000 | 265,000 | 34,126 | 467,874 | ||||||||
Debtors | 7,742,000 | -10,818,000 | 3,000,000 | 10,353,000 | 502,000 | -21,563,000 | 17,478,000 | 1,378,000 | 2,168,000 | 634,000 | 487,000 | 617,824 | -317,099 | 1,901,275 | |
Creditors | -1,301,000 | 136,000 | 600,000 | -503,000 | 637,000 | 69,739 | 357,698 | 3,563 | |||||||
Accruals and Deferred Income | 2,514,000 | -27,000 | -134,000 | -2,460,000 | 774,000 | -64,000 | -19,000 | 167,000 | 65,953 | 1,697,047 | |||||
Deferred Taxes & Provisions | -283,000 | 73,000 | 210,000 | ||||||||||||
Cash flow from operations | 21,860,000 | -20,111,000 | 10,957,000 | 4,549,000 | 2,079,000 | 2,323,000 | 776,742 | 2,527,969 | |||||||
Investing Activities | |||||||||||||||
capital expenditure | -393,000 | -272,000 | -189,000 | -341,000 | -417,000 | -242,733 | |||||||||
Change in Investments | 5,087,000 | 39,661,000 | 2,796,000 | -2,784,000 | 639,000 | -1,165 | 1,165 | ||||||||
cash flow from investments | -393,000 | -272,000 | -189,000 | -341,000 | -417,000 | -241,568 | |||||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | 6,310,000 | 29,025,000 | 3,875,000 | 9,702,000 | 785,000 | 37,000 | 1,000 | ||||||||
Other Short Term Loans | |||||||||||||||
Long term loans | |||||||||||||||
Hire Purchase and Lease Commitments | -14,000 | -7,000 | -6,836 | 27,836 | |||||||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | 3,819,000 | 68,963,000 | 8,000 | 28,000 | 18,000 | 5,000 | 1,798 | ||||||||
cash flow from financing | 10,129,000 | 97,988,000 | 3,875,000 | 9,702,000 | 785,000 | 37,000 | -19,463,000 | 751,000 | 174,000 | 199,000 | 2,000 | -60,500 | -537,174 | ||
cash and cash equivalents | |||||||||||||||
cash | -499,000 | -53,000 | 863,000 | -652,000 | 192,000 | 360,000 | -18,732,000 | 8,288,000 | 4,451,000 | 2,080,000 | 1,984,000 | 358,886 | 1,676,019 | 95 | |
overdraft | |||||||||||||||
change in cash | -499,000 | -53,000 | 863,000 | -652,000 | 192,000 | 360,000 | -18,732,000 | 8,288,000 | 4,451,000 | 2,080,000 | 1,984,000 | 358,886 | 1,676,019 | 95 |
Perform a competitor analysis for biocomposites (uk) limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mature companies, companies in ST5 area or any other competitors across 12 key performance metrics.
BIOCOMPOSITES (UK) LIMITED group structure
Biocomposites (Uk) Limited has 2 subsidiary companies.
Ultimate parent company
2 parents
BIOCOMPOSITES (UK) LIMITED
03854291
2 subsidiaries
Biocomposites (Uk) Limited currently has 5 directors. The longest serving directors include Mr John Bratt (Dec 1999) and Mr Simon Fitzer (May 2017).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr John Bratt | United Kingdom | 72 years | Dec 1999 | - | Director |
Mr Simon Fitzer | 62 years | May 2017 | - | Director | |
Mr Michael Harris | United Kingdom | 55 years | Jul 2019 | - | Director |
Mr Michael Harris | United Kingdom | 55 years | Jul 2019 | - | Director |
Mr Simon Greenhalgh | England | 53 years | Apr 2022 | - | Director |
P&L
December 2023turnover
0
0%
operating profit
4.6m
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
7m
+0.99%
total assets
59.3m
+0.26%
cash
317k
-0.61%
net assets
Total assets minus all liabilities
company number
03854291
Type
Private limited with Share Capital
industry
70100 - Activities of head offices
incorporation date
October 1999
age
26
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
grindco 268 limited (March 2013)
accountant
-
auditor
KPMG LLP
address
c/o biocomposites limited, keele science park, newcastle, staffs, ST5 5NL
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 3 charges/mortgages relating to biocomposites (uk) limited. Currently there are 2 open charges and 1 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOCOMPOSITES (UK) LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|